Viewing StudyNCT06162221

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 7:52 PM
Last Modification Date: 2024-10-26 @ 3:15 PM
Study NCT ID: NCT06162221
Status: RECRUITING
Last Update Posted: 2024-07-08
First Post: 2023-11-30
Brief Title: Study of RASON Inhibitor Combinations in Patients with Advanced RAS-mutated NSCLC
Sponsor: Revolution Medicines Inc
Organization: Revolution Medicines Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Non-Small Cell Lung Cancer NSCLC
KRAS NRAS HRAS-mutated NSCLC
KRAS G12C-mutated Solid Tumors Lung Cancer
Lung Cancer Stage IV Advanced Solid Tumor Cancer
Keywords:
Name View
NSCLC View
KRAS G12C View
RAS Mutation View
KRAS G12X View
Non-Small Cell Lung Cancer View
Lung Cancer View
Lung Cancer Stage IV View
Advanced Solid Tumor View
Cancer View